FDA rejects Agile's contraceptive patch, shares plunge

(Reuters) – Agile Therapeutics Inc said on Friday the U.S. Food and Drug Administration declined to approve its contraceptive patch for the second time, sending the drug developer’s shares down about 50 percent.

Source: Reuters Medical News